Stromal derived factor 1α: A chemokine that delivers a two-pronged defence of the myocardium

Pharmacology and Therapeutics

Volumn 143, Issue 3, 2014, Pages 305-315

  Bromage, Daniel I ^a   Davidson, Sean M ^a   Yellon, Derek M ^a  

^a Hatter Cardiovascular Institute   (United Kingdom)

Author keywords

AMI; Cardioprotection; CXCR4; DPP 4; Ischemic conditioning; SDF

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; STROMAL CELL DERIVED FACTOR 1ALPHA; CHEMOKINE RECEPTOR CXCR; CXCR7 PROTEIN, HUMAN; STROMAL CELL DERIVED FACTOR 1;

ACUTE HEART INFARCTION; ANGIOGENESIS; ARTICLE; CELL HOMING; CELL MIGRATION; DRUG MECHANISM; HALF LIFE TIME; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REPERFUSION INJURY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL MOBILIZATION; UPREGULATION; ANIMAL; HEART MUSCLE; METABOLISM;

ANIMALS; CHEMOKINE CXCL12; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HUMANS; MYOCARDIUM; RECEPTORS, CXCR; RECEPTORS, CXCR4;

EID: 84905215492     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2014.03.009     Document Type: Review

References (202)

1. J.D. Abbott, Y. Huang, D. Liu, R. Hickey, D.S. Krause, and F.J. Giordano Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury Circulation 110 2004 3300 3305
2. + progenitors to peripheral blood J Exp Med 185 1997 111 120
3. Z.A. Ali, C.J. Callaghan, E. Lim, A.A. Ali, S.A. Nouraei, and A.M. Akthar et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial Circulation 116 2007 I98 I105
4. G. Andreka, M. Vertesaljai, G. Szantho, G. Font, Z. Piroth, and G. Fontos et al. Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs Heart 93 2007 749 752
5. L. Argaud, O. Gateau-Roesch, D. Muntean, L. Chalabreysse, J. Loufouat, and D. Robert et al. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury J Mol Cell Cardiol 38 2005 367 374
6. L. Argaud, O. Gateau-Roesch, O. Raisky, J. Loufouat, D. Robert, and M. Ovize Postconditioning inhibits mitochondrial permeability transition Circulation 111 2005 194 197
7. P.W. Armstrong, C.B. Granger, P.X. Adams, C. Hamm, D. Holmes Jr., and W.W. O'Neill et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial JAMA 297 2007 43 51
8. A.T. Askari, and M.S. Penn Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration Discov Med 3 2003 46 47
9. A.T. Askari, S. Unzek, Z.B. Popovic, C.K. Goldman, F. Forudi, and M. Kiedrowski et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy Lancet 362 2003 697 703
10. + exchange inhibitors for cardioprotective therapy: progress, problems and prospects J Am Coll Cardiol 39 2002 747 753
11. C.P. Baines, R.A. Kaiser, N.H. Purcell, N.S. Blair, H. Osinska, and M.A. Hambleton et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death Nature 434 2005 658 662
12. K. Balabanian, B. Lagane, S. Infantino, K.Y. Chow, J. Harriague, and B. Moepps et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes J Biol Chem 280 2005 35760 35766
13. F.W. Bar, D. Tzivoni, M.T. Dirksen, A. Fernandez-Ortiz, G.R. Heyndrickx, and J. Brachmann et al. Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study Eur Heart J 27 2006 2516 2523
14. K.W. Baran, M. Nguyen, G.R. McKendall, C.T. Lambrew, G. Dykstra, and S.T. Palmeri et al. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study Circulation 104 2001 2778 2783
15. G.F. Baxter, M.M. Mocanu, B.K. Brar, D.S. Latchman, and D.M. Yellon Cardioprotective effects of transforming growth factor-beta1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK J Cardiovasc Pharmacol 38 2001 930 939
16. BCIS Audit Returns 2012: Adult Interventional Procedures (accessed March, 2014, at http://www.bcis.org.uk/resources/BCIS-Audit-2012-for-web-V2-14-10- 20131.pdf).
17. R.D. Berahovich, B.A. Zabel, S. Lewen, M.J. Walters, K. Ebsworth, and Y. Wang et al. Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels Immunology 141 1 2014 111 122
18. Y. Birnbaum, S.L. Hale, and R.A. Kloner Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit Circulation 96 1997 1641 1646
19. W.E. Boden, W.H. van Gilst, R.G. Scheldewaert, I.R. Starkey, M.F. Carlier, and D.G. Julian et al. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT) Lancet 355 2000 1751 1756
20. K. Boengler, A. Buechert, Y. Heinen, C. Roeskes, D. Hilfiker-Kleiner, and G. Heusch et al. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice Circ Res 102 2008 131 135
21. K. Boengler, D. Hilfiker-Kleiner, H. Drexler, G. Heusch, and R. Schulz The myocardial JAK/STAT pathway: from protection to failure Pharmacol Ther 120 2008 172 185
22. J.C. Bopassa, R. Ferrera, O. Gateau-Roesch, E. Couture-Lepetit, and M. Ovize PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning Cardiovasc Res 69 2006 178 185
23. J.C. Bopassa, D. Vandroux, M. Ovize, and R. Ferrera Controlled reperfusion after hypothermic heart preservation inhibits mitochondrial permeability transition-pore opening and enhances functional recovery Am J Physiol Heart Circ Physiol 291 2006 H2265 H2271
24. H.E. Botker, R. Kharbanda, M.R. Schmidt, M. Bottcher, A.K. Kaltoft, and C.J. Terkelsen et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial Lancet 375 2010 727 734
25. B.K. Brar, A.K. Jonassen, A. Stephanou, G. Santilli, J. Railson, and R.A. Knight et al. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway J Biol Chem 275 2000 8508 8514
26. E. Braunwald, and R.A. Kloner Myocardial reperfusion: a double-edged sword? J Clin Invest 76 1985 1713 1719
27. L. Candilio, A. Malik, and D.J. Hausenloy Protection of organs other than the heart by remote ischemic conditioning J Cardiovasc Med (Hagerstown) 14 2013 193 205
28. D.J. Ceradini, A.R. Kulkarni, M.J. Callaghan, O.M. Tepper, N. Bastidas, and M.E. Kleinman et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 Nat Med 10 2004 858 864
29. M. Chatterjee, and M. Gawaz Platelet-derived CXCL12 (SDF-1alpha): basic mechanisms and clinical implications J Thromb Haemost 11 11 2013 1954 1967
30. J. Chen, E. Chemaly, L. Liang, C. Kho, A. Lee, and J. Park et al. Effects of CXCR4 gene transfer on cardiac function after ischemia-reperfusion injury Am J Pathol 176 2010 1705 1715
31. Z. Cheng, L. Ou, X. Zhou, F. Li, X. Jia, and Y. Zhang et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance Mol Ther 16 2008 571 579
32. M.M. Cheung, R.K. Kharbanda, I.E. Konstantinov, M. Shimizu, H. Frndova, and J. Li et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans J Am Coll Cardiol 47 2006 2277 2282
33. K.W. Christopherson II, S. Cooper, and H.E. Broxmeyer Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells Blood 101 2003 4680 4686
34. K.W. Christopherson II, G. Hangoc, C.R. Mantel, and H.E. Broxmeyer Modulation of hematopoietic stem cell homing and engraftment by CD26 Science 305 2004 1000 1003
35. M.H. Cottler-Fox, T. Lapidot, I. Petit, O. Kollet, J.F. DiPersio, and D. Link et al. Stem cell mobilization Hematology Am Soc Hematol Educ Program 2003 419 437
36. M.P. Crump, J.H. Gong, P. Loetscher, K. Rajarathnam, A. Amara, and F. Arenzana-Seisdedos et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1 EMBO J 16 1997 6996 7007
37. Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients (CIRCUS) (accessed December, 2013, at http://clinicaltrials.gov/show/ NCT01502774).
38. S.M. Davidson, D. Hausenloy, M.R. Duchen, and D.M. Yellon Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection Int J Biochem Cell Biol 38 2006 414 419
39. S.M. Davidson, P. Selvaraj, D. He, C. Boi-Doku, R.L. Yellon, and J.M. Vicencio et al. Remote ischaemic preconditioning involves signalling through the SDF-1alpha/CXCR4 signalling axis Basic Res Cardiol 108 2013 377
40. E. De Clercq The bicyclam AMD3100 story Nat Rev Drug Discov 2 2003 581 587
41. I. Deglurkar, N. Mal, W.R. Mills, Z.B. Popovic, P. McCarthy, and E.H. Blackstone et al. Mechanical and electrical effects of cell-based gene therapy for ischemic cardiomyopathy are independent Hum Gene Ther 17 2006 1144 1151
42. A. Deussen, G. Moser, and J. Schrader Contribution of coronary endothelial cells to cardiac adenosine production Pflugers Arch 406 1986 608 614
43. F. Di Lisa, and P. Bernardi A CaPful of mechanisms regulating the mitochondrial permeability transition J Mol Cell Cardiol 46 2009 775 780
44. + and is a causative event in the death of myocytes in postischemic reperfusion of the heart J Biol Chem 276 2001 2571 2575
45. E.W. Dickson, M. Lorbar, W.A. Porcaro, R.A. Fenton, C.P. Reinhardt, and A. Gysembergh et al. Rabbit heart can be "preconditioned" via transfer of coronary effluent Am J Physiol 277 1999 H2451 H2457
46. E.W. Dickson, W.A. Porcaro, R.A. Fenton, S.O. Heard, C.P. Reindhardt, and F.P. Renzi et al. "Preconditioning at a distance" in the isolated rabbit heart Acad Emerg Med 7 2000 311 317
47. F. Dong, J. Harvey, A. Finan, K. Weber, U. Agarwal, and M.S. Penn Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction Circulation 126 2012 314 324
48. H. Dorge, R. Schulz, S. Belosjorow, H. Post, A. van de Sand, and I. Konietzka et al. Coronary microembolization: the role of TNF-alpha in contractile dysfunction J Mol Cell Cardiol 34 2002 51 62
49. J.M. Downey, and M.V. Cohen We think we see a pattern emerging here Circulation 111 2005 120 121
50. I. Elmadbouh, H. Haider, S. Jiang, N.M. Idris, G. Lu, and M. Ashraf Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium J Mol Cell Cardiol 42 2007 792 803
51. M. Esencay, Y. Sarfraz, and D. Zagzag CXCR7 is induced by hypoxia and mediates glioma cell migration towards SDF-1alpha BMC Cancer 13 2013 347
52. M. Faigle, J. Seessle, S. Zug, K.C. El Kasmi, and H.K. Eltzschig ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia PLoS One 3 2008 e2801
53. D.P. Faxon, R.J. Gibbons, N.A. Chronos, P.A. Gurbel, and F. Sheehan The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study J Am Coll Cardiol 40 2002 1199 1204
54. N.G. Frangogiannis, and M.L. Entman Chemokines in myocardial ischemia Trends Cardiovasc Med 15 2005 163 169
55. X. Freixa, N. Bellera, J.T. Ortiz-Perez, M. Jimenez, C. Pare, and X. Bosch et al. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention Eur Heart J 33 2012 103 112
56. R.M. Fryer, P.F. Pratt, A.K. Hsu, and G.J. Gross Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection J Pharmacol Exp Ther 296 2001 642 649
57. H. Gao, W. Priebe, J. Glod, and D. Banerjee Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium Stem Cells 27 2009 857 865
58. C. Gerard, and B.J. Rollins Chemokines and disease Nat Immunol 2 2001 108 115
59. S.K. Ghadge, S. Muhlstedt, C. Ozcelik, and M. Bader SDF-1alpha as a therapeutic stem cell homing factor in myocardial infarction Pharmacol Ther 129 2011 97 108
60. C.M. Gibson NRMI and current treatment patterns for ST-elevation myocardial infarction Am Heart J 148 2004 S29 S33
61. Global Atlas on Cardiovascular Disease Prevention and Control (accessed November, 2013, at http://whqlibdoc.who.int/publications/2011/9789241564373-eng. pdf).
62. M.D. Goodman, S.E. Koch, G.A. Fuller-Bicer, and K.L. Butler Regulating RISK: a role for JAK-STAT signaling in postconditioning? Am J Physiol Heart Circ Physiol 295 2008 H1649 H1656
63. C.B. Granger, K.W. Mahaffey, W.D. Weaver, P. Theroux, J.S. Hochman, and T.G. Filloon et al. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial Circulation 108 2003 1184 1190
64. E.J. Griffiths, and A.P. Halestrap Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts J Mol Cell Cardiol 25 1993 1461 1469
65. E.J. Griffiths, and A.P. Halestrap Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion Biochem J 307 Pt 1 1995 93 98
66. B. Gunaydin, I. Cakici, H. Soncul, S. Kalaycioglu, C. Cevik, and B. Sancak et al. Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery? Pharmacol Res 41 2000 493 496
67. H. Haider, S. Jiang, N.M. Idris, and M. Ashraf IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair Circ Res 103 2008 1300 1308
68. M.E. Halkos, F. Kerendi, J.S. Corvera, N.P. Wang, H. Kin, and C.S. Payne et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning Ann Thorac Surg 78 2004 961 969 (discussion 969)
69. D.J. Hausenloy, G. Baxter, R. Bell, H.E. Botker, S.M. Davidson, and J. Downey et al. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations Basic Res Cardiol 105 2010 677 686
70. D.J. Hausenloy, L. Candilio, C. Laing, G. Kunst, J. Pepper, and S. Kolvekar et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial Clin Res Cardiol 101 2012 339 348
71. D.J. Hausenloy, M.M. Mocanu, and D.M. Yellon Activation of the pro-survival kinases (PI3 kinase-Akt and Erk 1/2) at reperfusion is essential for preconditioning-induced protection Circulation 108 17 2003 62-62 (Abstract)
72. D.J. Hausenloy, P.K. Mwamure, V. Venugopal, J. Harris, M. Barnard, and E. Grundy et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial Lancet 370 2007 575 579
73. D.J. Hausenloy, A. Tsang, and D.M. Yellon The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning Trends Cardiovasc Med 15 2005 69 75
74. D.J. Hausenloy, H.J. Whittington, A.M. Wynne, S.S. Begum, L. Theodorou, and N. Riksen et al. Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner Cardiovasc Diabetol 12 2013 154
75. D.J. Hausenloy, and D.M. Yellon New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway Cardiovasc Res 61 2004 448 460
76. D.J. Hausenloy, and D.M. Yellon Preconditioning and postconditioning: united at reperfusion Pharmacol Ther 116 2007 173 191
77. D.J. Hausenloy, and D.M. Yellon Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection Heart Fail Rev 12 2007 217 234
78. D.J. Hausenloy, and D.M. Yellon Remote ischaemic preconditioning: underlying mechanisms and clinical application Cardiovasc Res 79 2008 377 386
79. D.J. Hausenloy, and D.M. Yellon Time to take myocardial reperfusion injury seriously N Engl J Med 359 2008 518 520
80. D.J. Hausenloy, and D.M. Yellon Myocardial ischemia-reperfusion injury: a neglected therapeutic target J Clin Invest 123 2013 92 100
81. D.J. Hausenloy, D.M. Yellon, S. Mani-Babu, and M.R. Duchen Preconditioning protects by inhibiting the mitochondrial permeability transition Am J Physiol Heart Circ Physiol 287 2004 H841 H849
82. P.A. Hernandez, R.J. Gorlin, J.N. Lukens, S. Taniuchi, J. Bohinjec, and F. Francois et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease Nat Genet 34 2003 70 74
83. G. Heusch, K. Boengler, and R. Schulz Cardioprotection: nitric oxide, protein kinases, and mitochondria Circulation 118 2008 1915 1919
84. F. Hoffmann, W. Muller, D. Schutz, M.E. Penfold, Y.H. Wong, and S. Schulz et al. Rapid uptake and degradation of CXCL12 depend on CXCR7 carboxyl-terminal serine/threonine residues J Biol Chem 287 2012 28362 28377
85. S.P. Hoole, P.M. Heck, L. Sharples, S.N. Khan, R. Duehmke, and C.G. Densem et al. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) study: a prospective, randomized control trial Circulation 119 2009 820 827
86. X. Hu, S. Dai, W.J. Wu, W. Tan, X. Zhu, and J. Mu et al. Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis Circulation 116 2007 654 663
87. S. Hu, H.L. Dong, Y.Z. Li, Z.J. Luo, L. Sun, and Q.Z. Yang et al. Effects of remote ischemic preconditioning on biochemical markers and neurologic outcomes in patients undergoing elective cervical decompression surgery: a prospective randomized controlled trial J Neurosurg Anesthesiol 22 2010 46 52
88. C. Huang, H. Gu, W. Zhang, M.C. Manukyan, W. Shou, and M. Wang SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury Am J Physiol Heart Circ Physiol 301 2011 H1496 H1505
89. Y.H. Jang, J.H. Kim, C. Ban, K. Ahn, J.H. Cheong, and H.H. Kim et al. Stromal cell derived factor-1 (SDF-1) targeting reperfusion reduces myocardial infarction in isolated rat hearts Cardiovasc Ther 30 2012 264 272
90. S.A. Javadov, S. Clarke, M. Das, E.J. Griffiths, K.H. Lim, and A.P. Halestrap Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart J Physiol 549 2003 513 524
91. Q. Jiang, P. Song, E. Wang, J. Li, S. Hu, and H. Zhang Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells J Mol Cell Cardiol 56 2013 1 7
92. A.K. Jonassen, M.N. Sack, O.D. Mjos, and D.M. Yellon Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling Circ Res 89 2001 1191 1198
93. M. Juhaszova, D.B. Zorov, S.H. Kim, S. Pepe, Q. Fu, and K.W. Fishbein et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore J Clin Invest 113 2004 1535 1549
94. K. Jujo, H. Hamada, A. Iwakura, T. Thorne, H. Sekiguchi, and T. Clarke et al. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction Proc Natl Acad Sci U S A 107 2010 11008 11013
95. T. Kamota, T.S. Li, N. Morikage, M. Murakami, M. Ohshima, and M. Kubo et al. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase J Am Coll Cardiol 53 2009 1814 1822
96. S. Kanki, V.F. Segers, W. Wu, R. Kakkar, J. Gannon, and S.U. Sys et al. Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium Circ Heart Fail 4 2011 509 518
97. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
98. F. Kerendi, H. Kin, M.E. Halkos, R. Jiang, A.J. Zatta, and Z.Q. Zhao et al. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors Basic Res Cardiol 100 2005 404 412
99. R.K. Kharbanda, U.M. Mortensen, P.A. White, S.B. Kristiansen, M.R. Schmidt, and J.A. Hoschtitzky et al. Transient limb ischemia induces remote ischemic preconditioning in vivo Circulation 106 2002 2881 2883
100. 2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion Am J Physiol Heart Circ Physiol 290 2006 H2024 H2034
101. K.C. Koch, W.M. Schaefer, E.A. Liehn, C. Rammos, D. Mueller, and J. Schroeder et al. Effect of catheter-based transendocardial delivery of stromal cell-derived factor 1alpha on left ventricular function and perfusion in a porcine model of myocardial infarction Basic Res Cardiol 101 2006 69 77
102. K. Kondo, S. Shintani, R. Shibata, H. Murakami, R. Murakami, and M. Imaizumi et al. Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis Arterioscler Thromb Vasc Biol 29 2009 61 66
103. M. Kucia, B. Dawn, G. Hunt, Y. Guo, M. Wysoczynski, and M. Majka et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction Circ Res 95 2004 1191 1199
104. M. Kucia, K. Jankowski, R. Reca, M. Wysoczynski, L. Bandura, and D.J. Allendorf et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion J Mol Histol 35 2004 233 245
105. M. Kucia, R. Reca, K. Miekus, J. Wanzeck, W. Wojakowski, and A. Janowska-Wieczorek et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis Stem Cells 23 2005 879 894
106. S.P. Kunuthur, M.M. Mocanu, B.A. Hemmings, D.J. Hausenloy, and D.M. Yellon The Akt1 isoform is an essential mediator of ischaemic preconditioning J Cell Mol Med 16 2012 1739 1749
107. L. Lacerda, S. Somers, L.H. Opie, and S. Lecour Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway Cardiovasc Res 84 2009 201 208
108. T. Lapidot, and I. Petit Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells Exp Hematol 30 2002 973 981
109. S. Lecour Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway? J Mol Cell Cardiol 47 2009 32 40
110. S. Lecour, N. Suleman, G.A. Deuchar, S. Somers, L. Lacerda, and B. Huisamen et al. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase) Circulation 112 2005 3911 3918
111. J.J. Lemasters, J.M. Bond, E. Chacon, I.S. Harper, S.H. Kaplan, and H. Ohata et al. The pH paradox in ischemia-reperfusion injury to cardiac myocytes EXS 76 1996 99 114
112. + cell mobilization after acute myocardial infarction Int J Cardiol 111 2006 202 208
113. C.H. Leung, L. Wang, J.M. Nielsen, M.B. Tropak, Y.Y. Fu, and H. Kato et al. Remote cardioprotection by transfer of coronary effluent from ischemic preconditioned rabbit heart preserves mitochondrial integrity and function via adenosine receptor activation Cardiovasc Drugs Ther 28 1 2013 7 17
114. J.P. Levesque, J. Hendy, Y. Takamatsu, P.J. Simmons, and L.J. Bendall Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide J Clin Invest 111 2003 187 196
115. W.C. Liles, H.E. Broxmeyer, E. Rodger, B. Wood, K. Hubel, and S. Cooper et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist Blood 102 2003 2728 2730
116. S.Y. Lim, D.M. Yellon, and D.J. Hausenloy The neural and humoral pathways in remote limb ischemic preconditioning Basic Res Cardiol 105 2010 651 655
117. H. Liu, S. Liu, Y. Li, X. Wang, W. Xue, and G. Ge et al. The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury PLoS One 7 2012 e34608
118. J. Lonborg, H. Kelbaek, N. Vejlstrup, E. Jorgensen, S. Helqvist, and K. Saunamaki et al. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance Circ Cardiovasc Interv 3 2010 34 41
119. Y. Maekawa, T. Anzai, T. Yoshikawa, Y. Sugano, K. Mahara, and T. Kohno et al. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction J Am Coll Cardiol 44 2004 1510 1520
120. A. Matsumori, Y. Furukawa, T. Hashimoto, A. Yoshida, K. Ono, and T. Shioi et al. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction J Mol Cell Cardiol 29 1997 419 423
121. M. Matsumoto-Ida, M. Akao, T. Takeda, M. Kato, and T. Kita Real-time 2-photon imaging of mitochondrial function in perfused rat hearts subjected to ischemia/reperfusion Circulation 114 2006 1497 1503
122. T.B. Mcclanahan, B.S. Nao, L.J. Wolke, B.J. Martin, T.E. Mertz, and K.P. Gallagher Brief renal occlusion and reperfusion reduces myocardial infarct size in rabbits FASEB J 7 3 1993 A118-A118 (Abstract)
123. K.E. McGrath, A.D. Koniski, K.M. Maltby, J.K. McGann, and J. Palis Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4 Dev Biol 213 1999 442 456
124. S.R. Mehta, S. Yusuf, R. Diaz, J. Zhu, P. Pais, and D. Xavier et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial JAMA 293 2005 437 446
125. P. Mertens, A. Maes, J. Nuyts, A. Belmans, W. Desmet, and E. Esplugas et al. Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial Am Heart J 152 125 2006 e121 e128
126. + cells in post-infarct cardiac repair mediated by G-CSF Cardiovasc Res 71 2006 455 465
127. P. Misra, D. Lebeche, H. Ly, M. Schwarzkopf, G. Diaz, and R.J. Hajjar et al. Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha J Nucl Med 49 2008 963 969
128. M.M. Mocanu, R.M. Bell, and D.M. Yellon PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning J Mol Cell Cardiol 34 2002 661 668
129. 2+ overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection Circ Res 89 2001 891 898
130. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
131. T. Nagasawa, S. Hirota, K. Tachibana, N. Takakura, S. Nishikawa, and Y. Kitamura et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 Nature 382 1996 635 638
132. T. Nagasawa, T. Nakajima, K. Tachibana, H. Iizasa, C.C. Bleul, and O. Yoshie et al. Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin Proc Natl Acad Sci U S A 93 1996 14726 14729
133. T. Nakagawa, S. Shimizu, T. Watanabe, O. Yamaguchi, K. Otsu, and H. Yamagata et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death Nature 434 2005 652 658
134. L. Opie The glucose hypothesis: relation to acute myocardial ischemia J Mol Cell Cardiol 1 1970 107 115
135. M. Ovize, G.F. Baxter, F. Di Lisa, P. Ferdinandy, D. Garcia-Dorado, and D.J. Hausenloy et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology Cardiovasc Res 87 2010 406 423
136. T. Oxman, M. Arad, R. Klein, N. Avazov, and B. Rabinowitz Limb ischemia preconditions the heart against reperfusion tachyarrhythmia Am J Physiol 273 1997 H1707 H1712
137. M.S. Penn, F.O. Mendelsohn, G.L. Schaer, W. Sherman, M. Farr, and J. Pastore et al. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure Circ Res 112 2013 816 825
138. M.S. Penn, J. Pastore, T. Miller, and R. Aras SDF-1 in myocardial repair Gene Ther 19 2012 583 587
139. I. Petit, M. Szyper-Kravitz, A. Nagler, M. Lahav, A. Peled, and L. Habler et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4 Nat Immunol 3 2002 687 694
140. K. Pillarisetti, and S.K. Gupta Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction Inflammation 25 2001 293 300
141. C. Piot, P. Croisille, P. Staat, H. Thibault, G. Rioufol, and N. Mewton et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction N Engl J Med 359 2008 473 481
142. H.M. Piper, D. Garcia-Dorado, and M. Ovize A fresh look at reperfusion injury Cardiovasc Res 38 1998 291 300
143. K. Przyklenk, B. Bauer, M. Ovize, R.A. Kloner, and P. Whittaker Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion Circulation 87 1993 893 899
144. R.T. Pyo, J. Sui, A. Dhume, J. Palomeque, B.C. Blaxall, and G. Diaz et al. CXCR4 modulates contractility in adult cardiac myocytes J Mol Cell Cardiol 41 2006 834 844
145. M.Z. Ratajczak, E. Zuba-Surma, M. Kucia, R. Reca, W. Wojakowski, and J. Ratajczak The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis Leukemia 20 2006 1915 1924
146. S. Ravassa, A. Zudaire, and J. Diez GLP-1 and cardioprotection: from bench to bedside Cardiovasc Res 94 2012 316 323
147. I. Rentoukas, G. Giannopoulos, A. Kaoukis, C. Kossyvakis, K. Raisakis, and M. Driva et al. Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action JACC Cardiovasc Interv 3 2010 49 55
148. K. Riesenberg, R. Levy, A. Katz, S. Galkop, and F. Schlaeffer Neutrophil superoxide release and interleukin 8 in acute myocardial infarction: distinction between complicated and uncomplicated states Eur J Clin Invest 27 1997 398 404
149. B.J. Rollins Chemokines Blood 90 1997 909 928
150. Safety and efficacy of SITAgliptin plus Granulocyte-colony stimulating factor in patients suffering from Acute Myocardial Infarction - SITAGRAMI trial (accessed 3rd March, 2014, at http://my.americanheart.org/idc/groups/ahamah- public/@wcm/@sop/@scon/documents/downloadable/ucm-458267.pdf).
151. L. Sanchez-Martin, P. Sanchez-Mateos, and C. Cabanas CXCR7 impact on CXCL12 biology and disease Trends Mol Med 19 2013 12 22
152. T. Sasaki, R. Fukazawa, S. Ogawa, S. Kanno, T. Nitta, and M. Ochi et al. Stromal cell-derived factor-1alpha improves infarcted heart function through angiogenesis in mice Pediatr Int 49 2007 966 971
153. A. Saxena, J.E. Fish, M.D. White, S. Yu, J.W. Smyth, and R.M. Shaw et al. Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction Circulation 117 2008 2224 2231
154. M.R. Schmidt, M. Smerup, I.E. Konstantinov, M. Shimizu, J. Li, and M. Cheung et al. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning Am J Physiol Heart Circ Physiol 292 2007 H1883 H1890
155. R. Schulz, S. Aker, S. Belosjorow, and G. Heusch TNFalpha in ischemia/reperfusion injury and heart failure Basic Res Cardiol 99 2004 8 11
156. B.M. Scirica, D.L. Bhatt, E. Braunwald, P.G. Steg, J. Davidson, and B. Hirshberg et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus N Engl J Med 369 2013 1317 1326
157. V.F. Segers, T. Tokunou, L.J. Higgins, C. MacGillivray, J. Gannon, and R.T. Lee Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction Circulation 116 2007 1683 1692
158. A. Segret, C. Rucker-Martin, C. Pavoine, J. Flavigny, E. Deroubaix, and M.A. Chatel et al. Structural localization and expression of CXCL12 and CXCR4 in rat heart and isolated cardiac myocytes J Histochem Cytochem 55 2007 141 150
159. H.P. Selker, J.R. Beshansky, P.R. Sheehan, J.M. Massaro, J.L. Griffith, and R.B. D'Agostino et al. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial JAMA 307 2012 1925 1933
160. F.C. Serejo, L.F. Rodrigues Jr., K.C. da Silva Tavares, A.C. de Carvalho, and J.H. Nascimento Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning J Cardiovasc Pharmacol 49 2007 214 220
161. S. Shanmuganathan, D.J. Hausenloy, M.R. Duchen, and D.M. Yellon Mitochondrial permeability transition pore as a target for cardioprotection in the human heart Am J Physiol Heart Circ Physiol 289 2005 H237 H242
162. Y. Shiba, M. Takahashi, T. Hata, H. Murayama, H. Morimoto, and H. Ise et al. Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis Cardiovasc Res 81 2009 169 177
163. M. Shimizu, M. Tropak, R.J. Diaz, F. Suto, H. Surendra, and E. Kuzmin et al. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection Clin Sci 117 2009 191 200
164. M. Shirozu, T. Nakano, J. Inazawa, K. Tashiro, H. Tada, and T. Shinohara et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene Genomics 28 1995 495 500
165. F. Sierro, C. Biben, L. Martinez-Munoz, M. Mellado, R.M. Ransohoff, and M. Li et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 Proc Natl Acad Sci U S A 104 2007 14759 14764
166. J.C. Simpkin, D.M. Yellon, S.M. Davidson, S.Y. Lim, A.M. Wynne, and C.C. Smith Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury Basic Res Cardiol 102 2007 518 528
167. C.C. Smith, R.A. Dixon, A.M. Wynne, L. Theodorou, S.G. Ong, and S. Subrayan et al. Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore Am J Physiol Heart Circ Physiol 299 2010 H1265 H1270
168. P. Sorensson, N. Saleh, F. Bouvier, F. Bohm, M. Settergren, and K. Caidahl et al. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction Heart 96 2010 1710 1715
169. P. Staat, G. Rioufol, C. Piot, Y. Cottin, T.T. Cung, and I. L'Huillier et al. Postconditioning the human heart Circulation 112 2005 2143 2148
170. S. Sundararaman, T.J. Miller, J.M. Pastore, M. Kiedrowski, R. Aras, and M.S. Penn Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure Gene Ther 18 2011 867 873
171. K. Tachibana, S. Hirota, H. Iizasa, H. Yoshida, K. Kawabata, and Y. Kataoka et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract Nature 393 1998 591 594
172. M. Takahashi Role of the SDF-1/CXCR4 system in myocardial infarction Circ J 74 2010 418 423
173. S. Tamareille, V. Mateus, N. Ghaboura, J. Jeanneteau, A. Croue, and D. Henrion et al. RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning Basic Res Cardiol 106 2011 1329 1339
174. J. Tang, J. Wang, H. Song, Y. Huang, J. Yang, and X. Kong et al. Adenovirus-mediated stromal cell-derived factor-1 alpha gene transfer improves cardiac structure and function after experimental myocardial infarction through angiogenic and antifibrotic actions Mol Biol Rep 37 2010 1957 1969
175. Y.L. Tang, W. Zhu, M. Cheng, L. Chen, J. Zhang, and T. Sun et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression Circ Res 104 2009 1209 1216
176. G. Tarantini, E. Favaretto, M.P. Marra, A.C. Frigo, M. Napodano, and L. Cacciavillani et al. Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial Int J Cardiol 162 2012 33 38
177. + progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM) Eur Heart J 28 2007 1258 1264
178. H. Thibault, C. Piot, P. Staat, L. Bontemps, C. Sportouch, and G. Rioufol et al. Long-term benefit of postconditioning Circulation 117 2008 1037 1044
179. M. Thielmann, E. Kottenberg, K. Boengler, C. Raffelsieper, M. Neuhaeuser, and J. Peters et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest Basic Res Cardiol 105 2010 657 664
180. M. Thielmann, E. Kottenberg, P. Kleinbongard, D. Wendt, N. Gedik, and S. Pasa et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial Lancet 382 2013 597 604
181. H. Tong, W. Chen, C. Steenbergen, and E. Murphy Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C Circ Res 87 2000 309 315
182. S. Unzek, M. Zhang, N. Mal, W.R. Mills, K.R. Laurita, and M.S. Penn SDF-1 recruits cardiac stem cell-like cells that depolarize in vivo Cell Transplant 16 2007 879 886
183. A. Valenzuela-Fernandez, T. Planchenault, F. Baleux, I. Staropoli, K. Le-Barillec, and D. Leduc et al. Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4 J Biol Chem 277 2002 15677 15689
184. V. Venugopal, D.J. Hausenloy, A. Ludman, C. Di Salvo, S. Kolvekar, and J. Yap et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial Heart 95 2009 1567 1571
185. J. Vinten-Johansen Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury Cardiovasc Res 61 2004 481 497
186. S.R. Walsh, J.R. Boyle, T.Y. Tang, U. Sadat, D.G. Cooper, and M. Lapsley et al. Remote ischemic preconditioning for renal and cardiac protection during endovascular aneurysm repair: a randomized controlled trial J Endovasc Ther 16 2009 680 689
187. W.B. White, C.P. Cannon, S.R. Heller, S.E. Nissen, R.M. Bergenstal, and G.L. Bakris et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes N Engl J Med 369 2013 1327 1335
188. P. Whittaker, and K. Przyklenk Reduction of infarct size in vivo with ischemic preconditioning: mathematical evidence for protection via non-ischemic tissue Basic Res Cardiol 89 1994 6 15
189. D. Wong, and W. Korz Translating an antagonist of chemokine receptor CXCR4: from bench to bedside Clin Cancer Res 14 2008 7975 7980
190. M.H. Yamani, N.B. Ratliff, D.J. Cook, E.M. Tuzcu, Y. Yu, and R. Hobbs et al. Peritransplant ischemic injury is associated with up-regulation of stromal cell-derived factor-1 J Am Coll Cardiol 46 2005 1029 1035
191. D.M. Yellon, and G.F. Baxter Reperfusion injury revisited: is there a role for growth factor signaling in limiting lethal reperfusion injury? Trends Cardiovasc Med 9 1999 245 249
192. D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury N Engl J Med 357 2007 1121 1135
193. M.M. Zaruba, and W.M. Franz Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy Expert Opin Biol Ther 10 2010 321 335
194. M.M. Zaruba, H.D. Theiss, M. Vallaster, U. Mehl, S. Brunner, and R. David et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction Cell Stem Cell 4 2009 313 323
195. + exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial J Am Coll Cardiol 38 2001 1644 1650
196. M. Zhang, N. Mal, M. Kiedrowski, M. Chacko, A.T. Askari, and Z.B. Popovic et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction FASEB J 21 2007 3197 3207
197. + cell homing to the infarcted heart Tissue Eng 13 2007 2063 2071
198. Z.Q. Zhao, J.S. Corvera, M.E. Halkos, F. Kerendi, N.P. Wang, and R.A. Guyton et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol 285 2003 H579 H588
199. Z.Q. Zhao, and J. Vinten-Johansen Postconditioning: reduction of reperfusion-induced injury Cardiovasc Res 70 2006 200 211
200. T. Zhao, D. Zhang, R.W. Millard, M. Ashraf, and Y. Wang Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling Am J Physiol Heart Circ Physiol 296 2009 H976 H986
201. Y.R. Zou, A.H. Kottmann, M. Kuroda, I. Taniuchi, and D.R. Littman Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development Nature 393 1998 595 599
202. J.L. Zweier Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury J Biol Chem 263 1988 1353 1357